Skip to main
GLUE
GLUE logo

GLUE Earnings Dates & Reports

GLUE Most Recent Earnings

Report DateNov 6, 2025
Period EndingQ3 2025
Est. EPS-$0.37
Actual EPS-$0.33
EarningsBeat

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

GLUE Earnings per Share (EPS) History

Signup for full access
Browse free

GLUE Latest Earnings

The value each GLUE share was expected to gain vs. the value each share gained.

GLUE reported its most recent earnings on Nov 6, 2025 for Q3 2025, posting earnings per share (EPS) of -$0.33. This exceeded analysts' expectations of -$0.37 by 10.81%, marking a Beat.

For comparison, Monte Rosa Therapeutics reported EPS of -$0.29 in the same quarter last year.

The company is expected to announce its next earnings report on 03/19/2026, with analysts projecting an EPS of -$0.38.

GLUE Earnings History

Earnings
Est. EPSActual EPSSurprise
Q4 2025Mar 20, 2026
-$0.38Next earnings call Mar. 19, 2026
Q3 2025Nov 6, 2025
-$0.37-$0.33-10.81%
DeckReportListen
Q2 2025Aug 7, 2025
-$0.34-$0.15-55.88%
DeckReportListen
Q1 2025May 8, 2025
-$0.32$0.57-278.12%
DeckReportListen
Q4 2024Mar 20, 2025
-$0.37$0.23-162.16%
DeckReportListen
View all

GLUE Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Monte Rosa Therapeutics’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
Nov 6, 2025
Aug 7, 2025
May 8, 2025
Mar 20, 2025

GLUE Earnings FAQs

GLUE last reported earnings on Nov 6, 2025 for Q3 2025, posting an EPS of -$0.33, which Beat the estimate of -$0.37 by 10.81%.

For Q3 2025, GLUE reported an EPS of -$0.33, exceeding analysts' estimate of -$0.37 by 10.81%.

For Q3 2025, GLUE Beat expectations with an actual EPS of -$0.33 vs. an estimated EPS of -$0.37.

Following the last earnings report on Nov 6, 2025, GLUE's stock price moved — from — to —.

The next GLUE earnings call is scheduled for Mar. 19, 2026, where executives will discuss financial results and outlook.

Monte Rosa Therapeutics (GLUE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.